La Prise en Charge du Cancer du Sein HER2 Positif

dc.contributor.advisorOUALLA KARIMA
dc.contributor.authorBELKECHRA Omar
dc.date.accessioned2023-09-19T15:08:55Z
dc.date.accessioned2026-01-28T15:19:06Z
dc.date.available2023-09-19T15:08:55Z
dc.date.issued2021
dc.description.collaboratorMELLAS NAWFEL
dc.description.collaboratorBOUCHIKHI CHAHRAZED
dc.description.collaboratorEL FATEMI HINDE
dc.description.collaboratorARIFI SAMIA
dc.description.collaboratorOUALLA KARIMA
dc.identifier.urihttps://toubkalpreprod.imist.ma/handle/123456789/24992
dc.language.isoFR
dc.publisherFaculté de Médecine et de Pharmacie, Fèsfr_FR
dc.subjectCancer du seinfr_FR
dc.subjectHER2 positiffr_FR
dc.subjectFacteurs de risquesfr_FR
dc.subjectChimiothérapiefr_FR
dc.subjectThérapie cibléefr_FR
dc.subject.otherOncologie médicale
dc.subject.specificOncologie médicale
dc.titleLa Prise en Charge du Cancer du Sein HER2 Positiffr_FR

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
333-21.pdf
Size:
7.4 MB
Format:
Adobe Portable Document Format